Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs

AIM: Until the year 2000, allogeneic haematopoietic cell transplantation (HCT) was the standard treatment for young and fit chronic myeloid leukaemia (CML) patients. CML was the main indication for allogeneic HCT. The introduction of tyrosine kinase inhibitors changed the treatment of CML patients...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Dominik Heim, Helen Baldomero, Michael Medinger, Stavroula Masouridi-Levrat, Urs Schanz, Gayathri Nair, Tayfun Güngör, Jörg Halter, Jakob R. Passweg, Yves Chalandon, Swiss Stem Cell Transplantation Group (SBST)
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2024-05-01
Schriftenreihe:	Swiss Medical Weekly
Online-Zugang:	https://smw.ch/index.php/smw/article/view/3754
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!